Bitter taste receptors profiling in the human blood-cerebrospinal fluid-barrier.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
07 2020
Historique:
received: 15 01 2020
accepted: 31 03 2020
pubmed: 7 4 2020
medline: 29 12 2020
entrez: 7 4 2020
Statut: ppublish

Résumé

The choroid plexus (CP) epithelial cells establish an important blood-brain interface, the blood-cerebrospinal fluid barrier (BCSFB), which constitutes a complementary gateway to the blood-brain-barrier for the entrance of several molecules into the central nervous system (CNS). However, the mechanisms that operate at the BCSFB to regulate the molecular traffic are still poorly understood. The taste signalling machinery, present in many extra-oral tissues, is involved in the chemical sensing of the composition of body fluids. We have identified this pathway in rat CP and hypothesised that it could also be present in the human BCSFB. In this study, we characterised the bitter taste receptors (TAS2Rs) expression profiling in human CP by combining data retrieved from available databases of the human CP transcriptome with its expression analysis in a human CP cell line and immunohistochemistry of human CP sections from men and women. TAS2R4, 5, 14 and 39 expression was confirmed in human CP tissue by immunohistochemistry and in HIBCPP cells by RT-PCR, immunofluorescence and Western blot. Moreover, the presence of downstream effector proteins GNAT3, PLCβ2 and TRPM5 was also detected in HIBCPP cells. Then, we demonstrated that HIBCPP cells respond to chloramphenicol via TAS2R39 and to quercetin via TAS2R14. Our findings support an active role of TAS2Rs at the human BCSFB, as surveyors of the bloodstream and CSF compositions. These findings open new avenues for studies on the uptake of relevant compounds for targeted therapies of the CNS.

Identifiants

pubmed: 32251676
pii: S0006-2952(20)30182-9
doi: 10.1016/j.bcp.2020.113954
pii:
doi:

Substances chimiques

Receptors, Cell Surface 0
Receptors, G-Protein-Coupled 0
TAS2R39 protein, human 0
taste receptors, type 2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113954

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ana C Duarte (AC)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

José Santos (J)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Ana R Costa (AR)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Catarina L Ferreira (CL)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Joana Tomás (J)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Telma Quintela (T)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Hiroshi Ishikawa (H)

Laboratory of Clinical Regenerative Medicine, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Christian Schwerk (C)

Pediatric Infectious Diseases, Department of Pediatrics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Horst Schroten (H)

Pediatric Infectious Diseases, Department of Pediatrics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Isidro Ferrer (I)

Department of Pathology and Experimental Therapeutics, University of Barcelona, Neuropathology, Bellvitge University Hospital-IDIBELL, CIBERNED, Hospitalet de Llobregat, Spain.

Eva Carro (E)

Instituto de Investigacion Hospital 12 de Octubre (i+12), Network Center for Biomedical Research in Neurodegenerative Diseases. CIBERNED, Madrid, Spain.

Isabel Gonçalves (I)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Cecília R A Santos (CRA)

CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH